Skip to main content

Research

GUMC is home to more than 400 scientists working on basic and clinical research projects and 300 active clinical trials. Last year GUMC research attracted $132 million in sponsored research, with the majority of those dollars coming from the federal government. Our researchers work in the lab, in the classroom, in the clinic, and in their communities to help answer medicine's biggest questions, focusing specifically on cancer, neuroscience, child health and development, and global health.

Main Content
featured story image

Study On Anti-Epilepsy Drugs in Newborns

Georgetown neuroscientists’ study in infant rats demonstrates an anti-epilepsy drug stunts neuronal growth, which could prompt new questions about using the first-line drug to treat epilepsy in human newborns.

Read More

featured story image

In Vino Vitalis? In Wine There Is Life?

Scott Turner is leading a national study testing resveratrol in participants with mild dementia due to Alzheimer’s disease, but he says a bigger question is whether high doses of the red wine compound resveratrol can reduce the risk of many diseases of aging.

Read More

featured story image

In Egypt, Small People With Big Status

Georgetown pediatrician’s curiosity about a statue in a Paris museum led to study of dwarfism in ancient Egypt. Her work provides a lesson in genetics as well as a tale of morality.

Read More